This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Collaborative Drug
FEBRUARY 7, 2024
Upcoming Webinar 3-21 24: Interdisciplinary Pathways in Medicine: Neurodegenerative Research and Drug Discovery
106 
Collaborative Drug
MARCH 22, 2024
Recorded Webinar 3-21 24: Interdisciplinary Pathways in Medicine: Neurodegenerative Research and Drug Discovery
103 This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Collaborative Drug
SEPTEMBER 15, 2023
Recorded Webinar: Drug Design Trends in the Age of AI. fragment-based drug design and full molecule-based drug design.
98 98 
Collaborative Drug
JUNE 28, 2023
Recorded Webinar: Artificial Intelligence Drug Discovery - Where are we now?
99 99 
Drug Discovery Today
JUNE 11, 2020
Webinar information:Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc.
Collaborative Drug
AUGUST 14, 2023
Upcoming Webinar: Drug design trends in the age of AI
95 95 
Drug Channels
JANUARY 18, 2022
Fein, CEO of Drug Channels Institute (DCI), for three live video webinars during 2022. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. Click here to order the Drug Channels 2022 Video Webinar Series. drug channel. drug channel.
88 
Drug Channels
MARCH 5, 2024
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.
85 
Drug Hunter
JUNE 29, 2023
In Wednesday’s Flash Talk webinar , we covered recent highlights in targeted protein degradation, with lots of great questions from the audience. The webinar and recording are available below to everyone thanks to our sponsor, Revvity Signals, and the slides are available for download to Premium members at the bottom.
Drug Channels
NOVEMBER 9, 2022
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2023. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. d/b/a Drug Channels Institute. to 1:30 p.m.
Drug Channels
JULY 5, 2022
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. d/b/a Drug Channels Institute. to 1:30 p.m.
85 
Collaborative Drug
DECEMBER 14, 2023
Discover breakthroughs in drug discovery with our recorded webinar. Susana Tomasio of CDD explores deep learning for similarity search in ChEMBL.
96 96 
Drug Channels
NOVEMBER 14, 2023
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. This event is part of The Drug Channels 2023 Video Webinar Series.
77 
Drug Hunter
SEPTEMBER 29, 2023
In Wednesday’s Flash Talk webinar, we covered recent highlights in covalent drug discovery, with lots of great questions from the audience. The webinar and recording are available below to everyone thanks to our sponsor, Revvity Signals, and the slides are available for download to Premium members at the bottom.
130 130 
Collaborative Drug
MAY 1, 2023
Upcoming Webinar: Artificial Intelligence Drug Discovery — Where are we now?
72 72 
Drug Channels
SEPTEMBER 14, 2022
I invite you to join me for three new video webinars during 2023. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. Click here to order the Drug Channels 2023 Video Webinar Series. d/b/a Drug Channels Institute.
73 
Drug Channels
SEPTEMBER 8, 2021
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest video webinar: Drug Channels Update: Buy-and-Bill Market Trends. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. d/b/a Drug Channels Institute. to 1:30 p.m.
74 
Drug Channels
MARCH 7, 2023
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook This event will be broadcast live on Friday, March 31, 2023, from 12:00 p.m. We use Zoom technology for this webinar.
84 
Collaborative Drug
DECEMBER 6, 2024
We recently hosted an insightful webinar featuring the team from Congruence Therapeutics , who shared how they're using CDD Vault alongside their proprietary systems to manage complex drug discovery data.
Collaborative Drug
SEPTEMBER 19, 2024
In a recent webinar, Janice Darlington from Collaborative Drug Discovery (CDD) with Tamsin Mansley from Optibrium discussed the importance of collaboration in drug discovery and showcased how their software platforms, CDD Vault and StarDrop , can enhance collaborative efforts.
99 99 
Collaborative Drug
AUGUST 14, 2024
Upcoming Webinar 3-21 24: Interdisciplinary Pathways in Medicine: Neurodegenerative Research and Drug Discovery
64 
Drug Channels
MARCH 29, 2022
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. d/b/a Drug Channels Institute. to 1:30 p.m.
Drug Channels
MAY 22, 2023
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding This event will be broadcast live on Friday, June 23, 2023, from 12:00 p.m. to 1:30 p.m.
73 
Drug Channels
SEPTEMBER 25, 2024
Drug Channel Institute is pleased to announce The Drug Channels 2025 Video Webinar Series. Fein for three live video webinars during 2025. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. drug channel.
52 
Nvidia Developer: Drug Discovery
JANUARY 2, 2024
Learn how the Francis Crick Institute is using NVIDIA Clara Parabricks to enable key parts of TRACERx EVO, a new program that builds on the discoveries made in.
98 
Collaborative Drug
AUGUST 14, 2024
Upcoming Webinar 3-21 24: Interdisciplinary Pathways in Medicine: Neurodegenerative Research and Drug Discovery
59 
FDA Law Blog: Biosimilars
JUNE 10, 2024
Last month the Department of Justice and the Drug Enforcement Administration submitted a notice of proposed rulemaking to reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. Hyman, Phelps & McNamara, P.C. Information and registration is available at the conference webpage here.
59 
Drug Channels
SEPTEMBER 20, 2023
Drug Channel Institute is pleased to announce The Drug Channels 2024 Video Webinar Series. Fein for three live video webinars during 2024. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. drug channel.
52 
FDA Law Blog: Biosimilars
MARCH 12, 2023
We will discuss the state of relevant laws prior to our new “COVID reality” and telemedicine issues during and post-pandemic, both with respect to the prescribing of controlled substances and non-controlled drugs. Please see detailed information in the attached flyer , including a link to register for our free webinar.
98 
Drug Channels
MAY 21, 2024
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.
52 
Collaborative Drug
AUGUST 1, 2023
Streamlining Collaborations and Drug Development using CDD Vault and ELN
Drug Channels
JANUARY 16, 2024
My recent Drug Channels Outlook 2024 webinar covered 12 key trends that will shape the commercial environment this year. The video excerpt below highlights my commentary on trend #2: the rapid growth of anti-obesity GLP-1 agonist drugs. Click here to sign up for The Drug Channels 2024 Video Webinar Series.
81 
FDA Law Blog: Biosimilars
DECEMBER 9, 2024
HPM) and Riparian LLC will co-host a webinar on an important CMS rule imposing penalties for misclassification of drugs and other reporting errors under the Medicaid Drug Rebate Program. The Webinar will explore the CMS rule and provide actionable recommendations for manufacturers on how to navigate the new requirements.
59 
Drug Channels
JULY 12, 2024
Gavin discusses the three key reasons for duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. To learn more, register for Kalderos’ August 21, 2024, webinar: Revolutionizing Government Discount Programs: Why Traditional Methods Fail. Read on for Gavin’s insights. All rights reserved.
94 
Alta Sciences
FEBRUARY 8, 2024
The FDA guidance, Evaluating Drug Effects on the Ability to Operate a Motor Vehicle , indicates that testing in early-phase clinical development should emphasize sensitivity over specificity in CNS effects. In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G.
Drug Channels
FEBRUARY 21, 2024
Below, I explain why the IRA will encourage Part D plans to prefer high-list, high-rebate specialty drugs , even as the government and manufacturers will prefer a low-list-price version. As always, I encourage you to share your own thoughts with the Drug Channels community on social media. Actually, maybe not. P.S. Want to learn more?
98 
Drug Channels
APRIL 21, 2022
This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: PBM Industry Update: Trends, Controversies, and Outlook. By reader request, we present below a channel flow chart illustrating the buy-and-bill process for provider-administered drugs. d/b/a Drug Channels Institute.
79 
Drug Channels
APRIL 12, 2022
As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. One bright spot: consumers will account for an ever-smaller share of drug spending. d/b/a Drug Channels Institute. healthcare spending. healthcare spending growth. to 1:30 p.m.
93 
Drug Channels
JANUARY 17, 2023
drug channels. If this clip whets your appetite for more, purchase a replay of the full 90 minute Drug Channels Outlook 2023 video webinar. Or register for my forthcoming 2023 video webinar series. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
Drug Channels
DECEMBER 5, 2023
Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription.
84 
FDA Law Blog: Biosimilars
JUNE 24, 2024
HPM) Director Dara Katcher Levy will present an informative webinar on the newly released AMCP Format for Formulary Submissions version 5.0. To register for this insightful webinar, visit AMCP Learn. This afternoon Hyman, Phelps & McNamara, P.C.
Drug Channels
DECEMBER 12, 2022
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2023. During Friday’s webinar, I’ll be sharing my updated thoughts about the IRA’s impact on manufacturers, Part D plans, and patient behavior. d/b/a Drug Channels Institute. 117-169).
97 
FDA Law Blog: Biosimilars
MAY 3, 2023
Accounting for controlled substances, maintaining complete and accurate records/reports and employing effective, compliant security do not alone guarantee a successful Drug Enforcement Administration (“DEA”) inspection. The webinar will share additional valuable inspection tips. Hyman, Phelps & McNamara, P.C. (“HP&M”)
Drug Channels
SEPTEMBER 7, 2022
As regular readers know, the biosimilar boom for provider-administered drugs has been accelerating. That’s when Humira, the best-selling drug in the U.S., The video is excerpted from last month’s Specialty Drugs Update: Trends, Controversies, and Outlook video webinar. d/b/a Drug Channels Institute.
88
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content